Carlos Luri-Rey
发表
I. Melero,
P. Berraondo,
E. Castañón,
2022,
Pharmacology & therapeutics.
Lieping Chen,
I. Melero,
M. Rodriguez-Ruiz,
2022,
Journal for ImmunoTherapy of Cancer.
G. Rabinovich,
I. Melero,
P. Berraondo,
2022,
Cell reports. Medicine.
I. Melero,
P. Berraondo,
C. D. de Andrea,
2022,
Cancer immunology research.
B. Sangro,
I. Melero,
P. Berraondo,
2023,
Cell reports. Medicine.
I. Melero,
M. Rodriguez-Ruiz,
P. Berraondo,
2023,
Oncoimmunology.
Lieping Chen,
I. Melero,
M. Sanmamed,
2022,
Cancer discovery.
J. Zapata,
I. Melero,
P. Berraondo,
2023,
Science advances.
I. Melero,
P. Berraondo,
Á. Teijeira,
2023,
Molecular therapy. Nucleic acids.
G. Rabinovich,
I. Melero,
P. Berraondo,
2023,
Cell reports. Medicine.
Lieping Chen,
I. Melero,
M. Rodriguez-Ruiz,
2022,
Cancer Research.
P. Berraondo,
Irene Olivera,
A. Cirella,
2023,
Expert opinion on therapeutic targets.
V. Verkhusha,
T. Kaisho,
I. Melero,
2022,
Cancer research.
I. Etxeberría,
Irene Olivera,
Carlos Luri-Rey,
2024,
Immuno-oncology technology.
Á. Teijeira,
Carlos Luri-Rey,
Beatrice Pinci,
2023,
Med.
M. Rodriguez-Ruiz,
P. Berraondo,
Á. Teijeira,
2024,
Clinical cancer research : an official journal of the American Association for Cancer Research.
Á. Teijeira,
Carlos Luri-Rey,
Javier Glez-Vaz,
2023,
Immunological reviews.
P. Berraondo,
S. Hervás-Stubbs,
Á. Teijeira,
2023,
EMBO molecular medicine.